SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001140361-24-024784
Filing Date
2024-05-08
Accepted
2024-05-08 07:00:48
Documents
56
Period of Report
2024-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q ef20026074_10q.htm   iXBRL 10-Q 884753
2 EXHIBIT 31.1 ef20026074_ex31-1.htm EX-31.1 12710
3 EXHIBIT 31.2 ef20026074_ex31-2.htm EX-31.2 12431
4 EXHIBIT 32.1 ef20026074_ex32-1.htm EX-32.1 7030
  Complete submission text file 0001140361-24-024784.txt   4602906

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA imcr-20240331.xsd EX-101.SCH 35278
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE imcr-20240331_cal.xml EX-101.CAL 46818
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE imcr-20240331_def.xml EX-101.DEF 184368
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE imcr-20240331_lab.xml EX-101.LAB 512635
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE imcr-20240331_pre.xml EX-101.PRE 294842
59 EXTRACTED XBRL INSTANCE DOCUMENT ef20026074_10q_htm.xml XML 528868
Mailing Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY
Business Address 90 PARK DRIVE MILTON PARK, ABINGDON OXFORDSHIRE X0 OX14 4RY 01235 5430281
Immunocore Holdings plc (Filer) CIK: 0001671927 (see all company filings)

IRS No.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39992 | Film No.: 24924179
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)